TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biogen Sweden AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
57,548
|
61,158
|
74,723 |
Financial expenses |
7
|
38
|
83 |
Earnings before taxes |
2,206
|
2,156
|
3,674 |
EBITDA |
2,049
|
2,219
|
3,796 |
Total assets |
22,781
|
22,511
|
26,898 |
Current assets |
22,764
|
22,479
|
26,832 |
Current liabilities |
5,422
|
6,876
|
11,729 |
Equity capital |
16,212
|
14,476
|
13,927 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
28
|
31
![]() |
31 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
71.2%
|
64.3%
|
51.8% |
Turnover per employee |
2,055
|
1,973
|
2,410 |
Profit as a percentage of turnover |
3.8%
|
3.5%
|
4.9% |
Return on assets (ROA) |
9.7%
![]() |
9.7%
|
14.0% |
Current ratio |
419.8%
|
326.9%
|
228.8% |
Return on equity (ROE) |
13.6%
|
14.9%
|
26.4% |
Change turnover |
-3,788
|
-7,512
|
9,502 |
Change turnover % |
-6%
|
-11%
|
15% |
Chg. No. of employees |
-3
|
0
|
-2 |
Chg. No. of employees % |
-10%
|
0%
|
-6% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.